Recist vs iRecist: Clinically Significant?

Recist vs iRecist: Clinically Significant?

User Photo
kidneycancer

1 year
112 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

Raquel Perez-Lopez Vall dHebron Institute of Oncology (VHIO)Principal Investigator-Radiomics Group discusses Recist vs iRecist: Clinically Significant? at the Kidney Cancer Association International Symposium 2019 at Dubrovnik, Croatia

 

 

 

 

recist vs irecist, kidney cancer association international symposium 2019, clinically significant

Up Next Autoplay